Belluscura (LSE:BELL) Days Payable: 371.38 (As of Jun. 2024)


What is Belluscura Days Payable?

Belluscura LSE:BELL Days Payable is 371.38 as of Jun. 2024.

Belluscura's average Accounts Payable for the six months ended in Jun. 2024 was £1.40 Mil. Belluscura's Cost of Goods Sold for the six months ended in Jun. 2024 was £0.69 Mil. Hence, Belluscura's Days Payable for the six months ended in Jun. 2024 was 371.38.

The historical rank and industry rank for Belluscura's Days Payable or its related term are showing as below:

LSE:BELL's Days Payable is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 68.07
* Ranked among companies with meaningful Days Payable only.

Belluscura's Days Payable declined from Jun. 2023 (773.57) to Jun. 2024 (371.38). It may suggest that Belluscura accelerated paying its suppliers.

Belluscura Days Payable Historical Data

* Premium members only.

The historical data trend for Belluscura's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Belluscura Days Payable Chart

Belluscura Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial 302.07 0.00 594.28 305.66 119.87

Belluscura Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 543.11 376.25 773.57 51.31 371.38

LSE:BELL vs ABT, BSX, SYK: Days Payable Comparison

For the Medical Devices subindustry, Belluscura's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Belluscura Days Payable vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Belluscura's Days Payable distribution charts can be found below:

* The bar in red indicates where Belluscura's Days Payable falls into.


Belluscura Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Belluscura's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (2.09 + 0.519) / 2 ) / 3.972*365
=1.3045 / 3.972*365
=119.87

Belluscura's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

Days Payable (Q: Jun. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2023 ) + Accounts Payable (Q: Jun. 2024 )) / count ) / Cost of Goods Sold (Q: Jun. 2024 )*Days in Period
=( (0.519 + 2.273) / 2 ) / 0.686*365 / 2
=1.396 / 0.686*365 / 2
=371.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 371.38 mean?
Belluscura (LSE:BELL) has a Days Payable of 371.38 as of Jun. 2024. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Belluscura and its competitors.
Is Belluscura's Days Payable too high?
Belluscura's current Days Payable is 371.38. The Medical Devices & Instruments industry median Days Payable is 68.07. Belluscura's value of 371.38 is 445.6% above this industry median.
How does Belluscura's Days Payable compare to ABT and BSX?
Belluscura's Days Payable of 371.38 can be compared against companies in the Medical Devices & Instruments industry. The industry median Days Payable is 68.07. Belluscura's value of 371.38 is 445.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Belluscura's current Days Payable of 371.38 is 445.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Belluscura and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Belluscura's current Days Payable is 371.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Belluscura stock overvalued right now?
Belluscura (LSE:BELL) has a current Days Payable of 371.38. The current Days Payable is 371.38 and 445.6% above the Medical Devices & Instruments industry median of 68.07. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Belluscura (LSE:BELL), the current Days Payable is 371.38 as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Belluscura Business Description

Address 15 Fetter Lane, Holborn, London, GBR, EC4A 1BW
Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The company has only one operating segment being the sale of oxygen concentrators in the United States. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.